...
首页> 外文期刊>The Journal of Allergy and Clinical Immunology >The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
【24h】

The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.

机译:C104R突变体通过单倍体不足而损害跨膜激活剂,钙调节剂和亲环素配体相互作用物(TACI)的功能。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: TNFRSF13B, which encodes transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), is mutated in 10% of patients with common variable immunodeficiency. One of the 2 most common TACI mutations in common variable immunodeficiency, C104R, abolishes ligand binding and is found predominantly in the heterozygous state. The murine TACI mutant C76R is the equivalent of the human TACI mutant C104R. OBJECTIVE: We sought to define the consequence of the C76R mutation on TACI function in mice that express both wild-type TACI and the murine C76R mutant. METHODS: Transgenic mice that express murine TACI C76R, the counterpart of human TACI C104R, on the TACI(+/-) B6/129 background (C76R/TACI(+/-) mice) were constructed. Serum immunoglobulins and antibody responses to the type II T-independent antigen trinitrophenylated (TNP)-Ficoll were determined by means of ELISA. B-cell proliferation in response to a proliferation-inducing ligand was determined based on tritiated thymidine incorporation into DNA. IgG1 secretion by B cells in response to a proliferation-inducing ligand plus IL-4 was determined by means of ELISA. RESULTS: C76R/TACI(+/-) mice had significantly impaired antibody responses to the type II T-independent antigen TNP-Ficoll compared with TACI(+/+) B6/129 control animals, and their B cells were impaired in their capacity to proliferate and secrete IgG1 in response to TACI ligation. Unexpectedly, TACI(+/-) mice had similarly impaired B-cell function as C76R/TACI(+/-) littermates. Impaired TACI function caused by haploinsufficiency was confirmed in TACI(+/-) mice on the C57BL/6 background. CONCLUSION: These results suggest that the human TACI mutant C104R might impair TACI function in heterozygotes through haploinsufficiency.
机译:背景:TNFRSF13B编码跨膜激活剂,钙调节剂和亲环素配体相互作用物(TACI),在10%的常见可变免疫缺陷患者中发生突变。 C104R是共同可变免疫缺陷中最常见的2种TACI突变之一,它消除了配体结合并主要处于杂合状态。鼠TACI突变体C76R等同于人TACI突变体C104R。目的:我们试图确定表达野生型TACI和鼠C76R突变体的小鼠中C76R突变对TACI功能的影响。方法:构建在TACI(+/-)B6 / 129背景上表达鼠TACI C104R(人类TACI C104R的对应物)的转基因小鼠(C76R / TACI(+/-)小鼠)。通过ELISA测定血清免疫球蛋白和对II型T非依赖性抗原三硝基苯化(TNP)-Ficoll的抗体应答。基于tri化胸腺嘧啶脱氧核苷掺入DNA确定响应于诱导增殖配体的B细胞增殖。通过ELISA确定响应增殖诱导配体加IL-4的B细胞分泌的IgG1。结果:与TACI(+ / +)B6 / 129对照动物相比,C76R / TACI(+/-)小鼠对II型非T型抗原TNP-Ficoll的抗体反应显着受损,并且它们的B细胞能力受损响应TACI连接而增殖和分泌IgG1。出乎意料的是,TACI(+/-)小鼠的B细胞功能与C76R / TACI(+/-)同窝仔小鼠相似。在C57BL / 6背景上的TACI(+/-)小鼠中证实了由单倍剂量不足引起的TACI功能受损。结论:这些结果表明,人TACI突变体C104R可能通过单倍体功能不足而损害杂合子中的TACI功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号